kras mutation and glutathion glynac The roles of in cancer metabolism, tumor microenvironment clinical therapy Mutant KRas-Induced Mitochondrial Oxidative Stress
Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





